0001629864-18-000001.txt : 20180703 0001629864-18-000001.hdr.sgml : 20180703 20180703122502 ACCESSION NUMBER: 0001629864-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 EFFECTIVENESS DATE: 20180703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AZTherapies, INC CENTRAL INDEX KEY: 0001629864 IRS NUMBER: 900747170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-315997 FILM NUMBER: 18935486 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET, 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-784-0490 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET, 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001629864 AZTherapies, INC 222 BERKELEY STREET, 12TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-784-0490 DELAWARE None None Corporation true David R. Elmaleh 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director Robert S. Warren 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Keith Greenfield 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director David Taft 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Director Ronald Tompkins 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Director Peter Conti 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Director John Porter 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Director Gillian Sandler 222 Berkeley Street, 12th Floor Boston MA MASSACHUSETTS 02116 Director Biotechnology Decline to Disclose 06b false 2018-06-18 false true true false 0 15000000 7725512 7274488 Amount offered and sold does not include the conversion of Convertible Promissory Notes in connection with the Initial Closing of the Financing. false 25 0 0 0 No payments have been proposed other than payments of salaries in the ordinary course of business. false AZTherapies, INC /s/ David R. Elmaleh, Ph.D. David R. Elmaleh, Ph.D. Chief Executive Officer 2018-07-03